We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KELYA:NASDAQKelly Services, Inc. Analysis

Data as of 2026-04-12 - not real-time

$8.71

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kelly Services trades around $8.71, just above its 20‑day SMA (8.69) but well below the 50‑day (9.37) and 200‑day (10.96) averages, indicating short‑term resilience but a longer‑term bearish bias. The RSI sits at 44, suggesting neutral momentum, while the MACD line is modestly above its signal, producing a small positive histogram that hints at limited upside momentum. Volatility is elevated at 24.6% over the past 30 days and the stock has experienced a historic drawdown of nearly 45%, underscoring substantial price swings. Despite a trailing PE of zero and a forward PE of 5.2—far below the industry average of 30.9—the company posted a -5.98% profit margin and a -11.9% revenue decline, reflecting ongoing earnings pressure. However, free cash flow remains positive at $170.6 M and the dividend yield of 3.44% is supported by a modest payout ratio of 26%, indicating current cash generation can sustain the payout.
Recent material news includes the appointment of Joel Leege as President of the Science, Engineering & Technology segment, signaling a strategic focus on higher‑margin talent solutions, and an insider purchase of 100 shares at $14.77, which, despite being well above market price, conveys confidence from management. The DCF‑derived fair value of $63.8 suggests a potential upside of over 90%, though such a gap may be tempered by execution risk. Overall, the stock appears deeply undervalued on a book‑value basis (price‑to‑book 0.30) and dividend yield, but faces significant execution and market‑timing challenges.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering just above short‑term support (8.29) with decreasing volume
  • Neutral momentum (RSI 44) and modest bullish MACD histogram
  • High short‑term volatility and bearish longer‑term moving averages

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward EPS estimate of $1.67 and low forward PE of 5.2
  • Strong free cash flow and sustainable dividend yield
  • Strategic leadership appointment and insider buying indicating confidence

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value implying >90% upside relative to current price
  • Deep discount to book value (price‑to‑book 0.30) and low valuation multiples
  • Potential sector recovery and continued cash‑flow generation despite current losses

Key Metrics & Analysis

Financial Health

Revenue Growth-11.90%
Profit Margin-5.98%
P/E Ratio5.2
ROE-22.98%
ROA1.40%
Debt/Equity16.29
P/B Ratio0.3
Op. Cash Flow$122.6M
Free Cash Flow$170.6M
Industry P/E30.9

Technical Analysis

TrendBearish
RSI43.9
Support$8.29
Resistance$9.20
MA 20$8.69
MA 50$9.37
MA 200$10.96
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09

Valuation

Fair Value$63.83
Target Price$16.67
Upside/Downside91.35%
GradeUndervalued
TypeValue
Dividend Yield3.44%

Risk Assessment

Beta0.91
Volatility24.59%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.